Evidence map›Paper›PMID 31501535›Full record

ArticleNature medicine2019

Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.

Paloma Cejas, Yotam Drier, Koen M A Dreijerink, Lodewijk A A Brosens, Vikram Deshpande, Charles B Epstein, Elfi B Conemans, Folkert H M Morsink, Mindy K Graham, Gerlof D Valk and 17 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Paloma Cejas *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Yotam Drier *Broad Institute of Harvard and MIT, Cambridge, MA, USA. yotam.drier@mail.huji.ac.il.ORCID http://orcid.org/0000-0003-1725-2995
Koen M A DreijerinkDepartment of Endocrine Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
Lodewijk A A BrosensDepartment of Pathology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
Vikram DeshpandeDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Charles B EpsteinBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-8358-8345
Elfi B ConemansDepartment of Endocrine Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
Folkert H M MorsinkDepartment of Pathology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
Mindy K GrahamDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gerlof D ValkDepartment of Endocrine Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
Menno R VriensDepartment of Surgical Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
Carlos Fernandez-Del CastilloDepartment of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Cristina R FerroneDepartment of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Tomer AdarDepartment of Gastroenterology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Michaela BowdenDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Holly J WhittonBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Annacarolina Da SilvaDepartment of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
Alba Font-TelloCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Henry W LongCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Elizabeth GaskellBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Noam ShoreshBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Christopher M HeaphyDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-4264-1810
Ewa SicinskaDepartment of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
Matthew H KulkeDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Daniel C ChungDepartment of Gastroenterology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Bradley E BernsteinBroad Institute of Harvard and MIT, Cambridge, MA, USA. bernstein.bradley@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-5726-6278
Ramesh A ShivdasaniDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ramesh_shivdasani@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-2828-1727

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31501535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.